Table 3 Overall survival in AFD, TMB and Kaplan–Meier estimates in the validation group
Variable | Low-value group (n = 36) | High-value group (n = 12) |
|---|---|---|
AFD | ||
 Deaths—no. (%)a | 2 | 5 |
 Data censoredb | 34 | 7 |
 Median overall survival—mo (95% CI) | NE | NE |
 The overall survival (95% CI) by Kaplan–Meier estimation | ||
 23 mo | 97.1% (91.5–100) | NA |
 25 mo | NA | 66.7% (44.7–99.5) |
 27 mo | 94.1% (86.5–100) | 58.3% (36.2–94.1) |
TMB | ||
 Deaths—no. (%)a | 4 | 3 |
 Data censoredb | 32 | 9 |
 Median overall survival—mo (95% CI) | NE | NE |
 The overall survival (95% CI) by Kaplan–Meier estimation | ||
 10 mo | 97.2 (92.0–100) | NA |
 8 mo | NA | 91.7 (77.3–100) |
 27 mo | 88.5 (78.6–99.8) | 75.0 (54.1–100) |